GeckoSystems in Final Negotiations to License AI Mobile

New Post Public Reply Private Reply Replies (1) Message Board
mech66 wavelength #484

GeckoSystems in Final Negotiations to License AI Mobile Robot Solutions

CONYERS, GA, May 16, 2013 -- GeckoSystems Intl. Corp. (Pink Sheets: GOSY | http://www.geckosystems.com/) has announced that final negotiations for licensing of their "Mobile Robot Solutions for Safety, Security and Service™" are ongoing.  This first joint venture and licensing agreement has been long sought by the management of GeckoSystems as irrefutable proof of the benefit and "value proposition" of their many years of R&D, testing, and marketing.

This party understands the breadth of the Mobile Service Robots (MSR's) market and is motivated to establish itself as the dominant regional developer, manufacturer, and marketer.  In addition, the prospective licensee has expressed intent to develop and market GeckoSystems' numerous product concepts such as the ChairBot™, SecurityBot™, GeckoNED™, and GeckoSuperSentinel™.

http://www.geckosystems.com/high_level/

"Over the last several years, we have entered into dozens of non-disclosure agreements and many Memorandums Of Understanding (MOU's), all in good faith, but for various reasons we have been unable to finalize a licensing agreement and initiate the technology transfers to enable production.  Due to the sincerity of this party's interest and the depth of their business acumen, I am the most confident I have ever been that we will soon be announcing a 'done deal' and realizing our first licensing revenues before the end of our fiscal year," reflected Martin Spencer, President/CEO, GeckoSystems Intl. Corp. GeckoSystems' AI mobile robot solutions are unique in that they are portable and extensible, enabling ready migration and usage to a large number of MSR applications and marketplaces.  Using GeckoSystems' proprietary technology, licensees are able to develop new products quickly and with reduced R&D cost, giving them a competitive edge that is "fast to market" when entering new markets. In addition, GeckoSystems' robust hardware and software architecture makes applications based on their technology "obsolescence proof" because new technology and/or cost reduction can be integrated on a modular basis as it develops.

"While we remain focused on our Pacific Rim business development activities, we now have new, ongoing discussions in several EU and Mediterranean countries.  These discussions are primarily in the areas of commercial security and professional healthcare.  We generally get favorable reactions and heightened interest due to our willingness to share risk in the proposed joint ventures," commented Spencer.

In 2010 the AI navigation software developed for and used on the CareBot® was migrated and with limited, additional R&D the company was able to create the SafePath® "collision free" power wheelchair upgrade.   This migration proved the extensible and portable nature of GeckoSystems' AI mobile robot architecture and its ability to accelerate development of additional MSR applications.  This is why GeckoSystems is gaining worldwide recognition in the robotics field.   Research and Markets recently identified GeckoSystems as one of eight "key market players" along side Honda, iRobot, Sony, Toyota, and others.  The company is delighted to receive this global recognition.

GeckoSystems' Japanese associate, ZMP has graciously hosted several demonstrations of the company's technologies in their office in Tokyo using the BaseBot® that was shipped to them a year ago.   The BaseBot® demonstrates SafePath®, the world's first and only AI navigation system capable of "sense and avoid" of not only stationary obstacles, but also dynamic obstacles, while seeking the user's desired destination.

ZMP's evaluation of the BaseBot® was very favorable.  ZMP of Japan, a long established vendor of robotic research platforms, has confirmed that the navigation system used in the BaseBot (and hence CareBot, etc.) is "sophisticated" and "fully developed."

http://www.geckosystems.com/investors/press_r...aseBot.php

http://www.zmp.co.jp/html/press_20120924.htm

http://www.geckosystems.com/partners/about_zmp.php

Due to these recent demonstrations, GeckoSystems is in ongoing discussions concerning joint ventures and/or licensing of their proprietary technologies to develop products in the security and healthcare sectors in China, Japan, Taiwan, and the EU and one Mediterranean country.   There are world wide demographic changes that are expanding opportunities in the health care market globally, but in the Pacific Rim, EU and Mediterranean, the need is urgent and GeckoSystems complete suite of mobile robot solutions offers a distinct competitive advantage because of being "fast to market."

In March of 2015 the Japanese national health care plan will begin to cover robotic personal assistance applications at a rate of 90%.   Because of the demographic issues outlined in the report below a CareBot® type personal robot designed to help people live independently in their own home as long as possible will be in high demand.   GeckoSystems believes that no economically viable solution can be developed for this market by that March 2015 date without using their technology.

http://www.geckosystems.com/downloads/SafePat...nefits.pdf

http://www.geckosystems.com/investors/GeckoSy...arkets.pdf

"We continue to be very pleased with the hard work and demonstrable progress made by our associates, Mssrs. Hajime Yasumatsu and Katsuji Fujii, in locating, qualifying and presenting to interested Asian businesses that could benefit from our technology.   Recently we have had increased activity and serious discussions in the EU and Mediterranean markets.   Due to the sensitivity and delicacy of these ongoing and upcoming joint venture discussions, it would be imprudent for us to reveal additional details at this time.  I remain personally grateful for our 1300+ stockholders' loyal support and look forward to their being rewarded with a satisfying ROI," concluded Spencer.

GeckoSystems Intl. Corp. (GOSY) Stock Research Links

GOSY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading